No Detail Found!

Intralesional Triamcinolone Alone Vs. Combined Platelet-Rich Plasma for Keloid Treatment

Author(s)
Imtiaz Khan Afridi Department of Dermatology, Hayatabad Medical Complex,Peshawar,Pakistan
Shah Fiaz Department of Dermatology, Hayatabad Medical Complex,Peshawar,Pakistan
Aiman Wazir Department of Dermatology, Hayatabad Medical Complex,Peshawar,Pakistan
Salma Noreen Department of Dermatology, Hayatabad Medical Complex,Peshawar,Pakistan
Abstract
Objective: To compare the e cacy of intralesional triamcinolone acetonide alovnersus its combination with platelet-rich plasma (PRP) in the treatment of keloids. Study Design: Quasi-experimental study. Place and Duration of the Study: Department of Dermatology, MTI-Hayatabad Medical Complex, Peshawar, Pakistan, from March to September 2022. Methodology: Sixty patients with refractory keloids were enrolled and randomly assigned to two equal groups. Group A received intralesional triamcinolone acetonide (20 mg/mL) injections every three weeks for a total of four sessions. Group B received the same regimen of triamcinolone, supplemented with autologous PRP injections administered one week after each corticosteroid session. PRP was prepared using a two-step centrifugation technique and activated with calcium chloride before intralesional injection. Treatment response was assessed using the Vancouver scar scale (VSS) at 12 weeks. Data were analysed using SPSS version 23.0, with a p-value d0.05 considered statistically signi cant. Results: Signi cant clinical improvement (e50% VSS reduction) was observed in 86.7% of patients in Group B compared to 33.3% in Group A (p <0.001). Conclusion: Combining intralesional triamcinolone acetonide with PRP is signi cantly more e ective than corticosteroid monotherapy in the treatment of keloids.
Publication Details
Page(s) 922-925
Published Journal: Journal of the College of Physicians and Surgeons Pakistan, Volume: 35, Issue: 07, Year: 2025

Request the full text from PASTIC

Keywords
Keloids, platelet-rich plasma, intralesional triamcinolone acetonide, Scar therapy
References
Shaheen A .2017 .Comprehensive review of keloid formation. Clin Res Dermatol, 4(5) : 1-8.
Wang ZC,Zhao WY,Cao Y,Liu YQ,Sun Q,Shi P .2020 .The roles of in ammation in keloid and hypertrophic scarsF. ront Immunol, 603187 : 603187.
Goutos I,Ogawa R .2017 .Steroid tape: A promising adjunct to scar management. Scars Burn Heal, 10 : 205951311.
Coppola MM,Salzillo R,Segreto F .2018 .Triamcinolone acetonide intralesional injection for the treatment of keloid scars: Patient selection and perspectives. Clin Cosmet Investig Dermatol, 10 : 387-96.
Chicharro-Alcantara D,Rubio-Zaragoza M,Damia-Gimenez E,Carrillo-Poveda JM,Cuervo-Serrato B,Pelaez-Gorrea P .2018 .Platelet-rich plasma: New insights for cutaneous wound healing management. J Funct Biomater, 10(1) : 10.
Klosova H,Stetinsky J,Bryjova I,Hledik S .2013 .Objective evaluation of the e ect of autologous platelet concentrate on post-operative scarring in deep burns. Burns, 01(6) : 1263-76.
Obolenskiy VN,Ermolova DA,Laberko LA,Semenova TV LA .2014 .E cacy of platelet-rich plasma for the treatment of chronic wounds. EWMA J, 14(1) : 37-41.
Kim DH,Je YJ,Kim CD,Lee YH,Seo YJ,Lee JH .2011 .Can platelet-rich plasma be used for skin rejuvenation? Evaluation of e ects of platelet-rich plasma on human dermal broblast. Ann Dermatol, 23(4) : 424-31.
Zhang M,Park G,Zhou B,Luo D .2018 .Applications and e cacy of platelet-rich plasma in dermatology: A clinical review. J Cosmet Dermatol, 10(5) : 660-5.
Zhang X,Zhang C,Ren H C .2020 .Comparison of triamcinolone acetonide and platelet-rich plasma for keloid treatment: A randomized controlled trial. Int J Dermatol, 1730742(3) : 343-50.
Kim YJ,Lee WJ,Lee SJ .2019 .The e cacy of combining plateletrich plasma with triamcinolone acetonide for the treatment of keloids: A clinical trial. Plast Reconstr Surg, 143(1) : 25-33.
Faghih Z,Ebrahimi T,Saki N. .2022 .Role of platelet-rich plasma in treating keloid scars: A clinical study. Dermatol Ther, 35(1) : e15291.
Wang X,Jiang H,Li Y,Li Y,Li J,Li H .2023 .E ects of plateletrich plasma combined with corticosteroids on hypertrophic scars and keloids: A clinical and molecular study. J Cosmet Dermatol, 22(2) : 487-94.
Park JH,Lee SY,Lee KS,Kim JY,Lee SJ,Kim WS .2020 .Molecular mechanisms underlying the e ects of platelet-rich plasma combined with corticosteroids in keloid treatment. Exp Dermatol, 29(8) : 786-94.
Lee JS,Kim HK,Park YK,Kim BJ,Kim MN,Kang H .2022 .Long-term outcomes of keloid treatment with intralesional triamcinolone acetonide and platelet-rich plasma: A randomized controlled trial. Dermatol Surg, 48(1) : 45-52.
Alharbi M,Awad A,El-Sayed M. .2021 .The impact of platelet-rich plasma on scar elasticity and patient satisfaction in keloid treatment: A prospective study. Aesthetic Plast Surg, 45(6) : 1589-96.
Kumar S,Singh K,Khosla A .2023 .E cacy of platelet-rich plasma in reducing keloid recurrence when combined with intralesional triamcinolone: A controlled study. J Cosmet Dermatol, 22(1) : 78-85.
Sagheer A,Shehzad A,Hussain I .2016 .Comparison of e cacy of intralesional 5- uorouracil alone versus intralesional triamcinolone acetonide with 5- uorouracil in small keloids. J Pak Assoc Dermatol, 26(4) : 361-5.
0

Citations

0

Downloads

54

Views